| Drugs by Condition |  |
Reversal of Nondepolarizing Muscle Relaxants Medications
Drugs associated with Reversal of Nondepolarizing Muscle Relaxants
The following drugs and medications are in some way related to, or used in the treatment of Reversal of Nondepolarizing Muscle Relaxants. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
||
|---|---|---|---|---|
Mestinon (Pro, More...) generic name: pyridostigmine class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
| Tensilon (More...)generic name: edrophonium class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
| Mestinon Timespan (More...)generic name: pyridostigmine class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
| Enlon (Pro, More...)generic name: edrophonium class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
| Regonol (More...)generic name: pyridostigmine class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
| Enlon-Plus (More...)generic name: atropine/edrophonium class: cholinergic muscle stimulants | 0 review(s) | Not rated - Be the first | ||
Reversal of Nondepolarizing Muscle Relaxants Medications in the Pipeline
Sugammadex
- August 1, 2008 - U.S. FDA Issues Action Letter for Sugammadex
- March 12, 2008 - FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
- January 3, 2008 - Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
